- Abstract
- Core Tip
- Article Highlights
- Full Article with Cover (PDF)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (1033)
- Timeline of Article Publication (1)
- Authors Evaluation (4)
- Article Quality Tracking (1)
- Reader Comments (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5006)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 14, 2021 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiang ZN, Ahmed SMU, Wang QC, Shi HF, Tang XW. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival. World J Gastroenterol 2021; 27(22): 3085-3096 [PMID: 34168410 DOI: 10.3748/wjg.v27.i22.3085] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i22/3085.htm |
| Number | Citing Articles |
| 1 |
Lei Cao, Yuanqin Chen, Shuangta Xu, Hongwei Cheng. Is NAD(P)H quinone oxidoreductase 1 a tumor promoter or suppressor in gastric cancer?. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1143108
|
| 2 |
Ran Xu, Ying Liu, Liang Ma, Yao Sun, Haifeng Liu, Yang Yang, Tiefeng Jin, Dawei Yang. NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation. Acta Biochimica et Biophysica Sinica 2023; 55(5): 758 doi: 10.3724/abbs.2023066
|
| 3 |
Giovanni Tossetta, Daniela Marzioni. Targeting the NRF2/KEAP1 pathway in cervical and endometrial cancers. European Journal of Pharmacology 2023; 941: 175503 doi: 10.1016/j.ejphar.2023.175503
|